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Only few structures for some specific metrics, such as Dmean 
rectum and D98% parotid glands exhibited deviations larger 
than 3%. g-analysis (2%, 1mm) on the three planes at 
isocenter showed a pass-rate higher than 98% for all cases. 
Clinical evaluation in ten patients showed very good 
agreement with the dose calculation on the CT as expressed 
by the D2%, D98% and Dmean of the delineated structures. 
Several drawbacks were also found: the limited FOV of the 
kV-CBCT, which impairs the dose evaluation of those 
structures in its vicinity and the difference in beam profile of 
the kV-CBCT with respect to the CT, reducing the accuracy of 
the dose estimation at nearby the surface of the patient.  
Conclusions: The generation of three kV-CBCT specific HU-
RED curves for the pelvis, thorax and H&N cases resulted in 
accurate dose calculation on kV-CBCT images. Very good 
agreement was found with the CT-based dose calculated 
plans according to DVH dose parameters and g-evaluation. 
Limitations of the kV-CBCT warrant some caution when 
evaluating dose differences for adaptive radiotherapy. 
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Purpose/Objective: Given the complexity of modulated 
fields, the validity of the traditional central axis FSD 
measurement is now being questioned. This study aims to 
quantify the impact a change in patient body contour, away 
from the central axis, has on target dose when treating dose 
escalated image guided IMRT and VMAT for definitive and 
post prostatectomy prostate cancer. 
Materials and Methods: A total of 39 patients, 22 definitive 
and 17 post prostatectomy, were included in this 
retrospective dosimetric study. Both IMRT and VMAT plans 
were calculated with a prescription dose of 80Gy and 64Gy 
for definitive and post surgical cases respectively. The 
treatment plan was applied to each of the patients’ weekly 
cone beam scans and all plans were recalculated with the 
homogeneity correction inactivated allowing for direct 
dosimetric comparison. FSDs were recorded for each IMRT 
field on each scan. The CTV D100, PTV D98, PTV D95, PTV 
D2, PTV mean and PTV median doses along with the 98% and 
95% conformity indices and homogeneity index were recorded 
for all 712 plans analyzed. Statistical analysis included 
repeated measures ANOVA and Freidman’s tests for the 
whole treatment course. Individual CBCT dependant variables 
were further analysed using paired samples T tests and 
Wilcoxon Signed Rank tests. 
Results: A total of 712 plans were created, 6408 dependant 
variables analysed and 2502 FSD measurements recorded. Of 
the FSD measurements taken from CBCTs for the IMRT plans, 
96.3% and 100% were within 1cm from the planned value for 
definitive and post prostatectomy patients respectively. For 
the definitive cohort, an increase in dose was observed 
across each metric measured (p<0.05). Subsequent analysis 
revealed 83.3% of individual measurements from CBCTs were 
significantly different (p<0.05) from the original planned 
value. For the post prostatectomy cohort only the IMRT 
homogeneity index (p=0.000) and the VMAT PTV D98 
(p=0.009), 98% (p=0.006) and 95% (p=0.002) conformity 
indices and homogeneity index (p=0.022) were significantly 
different from the planned value based on measures of 
variance. Analysis of the individual CBCTs for this group 
revealed 88% and 71.4% of endpoints measured were 
statistically similar to the original plan for IMRT and VMAT 
respectively. 
Conclusions: IMRT and VMAT beams are complex in nature. 
The endpoints analysed in this research indicate statistical 
differences to target doses despite the FSD measurements 
being within the nominal tolerance. The traditional central 
axis measurement is an insufficient indicator for dosimetric 
variation with modulated beams. As such a volumetric 
approach to contour variation, through the use of CBCT, is 
essential when treating with IMRT or VMAT. 
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Purpose/Objective: The use of IMRT for cervical cancer can 
significantly reduce dose to normal tissue. However, there is 
substantial uterine motion during treatment resulting from 
variation in bladder and rectal filling and this risk of a 
geographical miss has limited the implementation of IMRT. A 
population based CTV-PTV margin requires 15-30mm to 
ensure coverage throughout treatment but this encompasses 
large volumes of normal tissue. Daily online imaging with an 
adaptive approach may reduce margins but is very resource 
intensive. IMRT can still be safely introduced if internal 
motion throughout treatment can be accurately predicted to 
individualise volumes. 
Our aim was to assess whether variable bladder filling scans 
can be used to predict uterine position during treatment and 
compare methods for generating the final PTV. 
Materials and Methods: A retrospective analysis was 
performed of 11 patients treated with primary chemo-
radiotherapy for cervical carcinoma. Patients underwent 
‘bladder full’ radiotherapy planning scans and ‘bladder 
empty’ pre-treatment diagnostic imaging, with images co-
registered on the treatment planning software. The uterus 
and cervix were contoured on the planning scan to generate 
the CTVuterus and an isotropic 15mm expansion made to 
generate the unmodified PTVuterus. A manually modified PTV 
was made by the clinician taking into account the change in 
uterine position between scans. CBCT verification was 
performed weekly during treatment. The unmodified and 
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modified PTVs were overlaid and compared on each of the 
diagnostic, planning and verification scans, and coverage of 
tumour classified as well covered, borderline or not covered. 
Our second approach involved forming an ITV as a composite 
volume of the uterus on the bladder full and bladder empty 
scans. Isotropic expansions of 7, 10, 12 and 15mm were then 
applied to determine if a composite PTV would consistently 
encompass the target on CBCT images. 
Results: A total of 40 CBCT images were reviewed for 11 
patients. The unmodified PTV did not fully cover the target in 
16/40 scans (40%) and on at least one scan in 6/11 patients 
(55%). Modified PTV’s provided full coverage on every scan 
but one (98% coverage) in which the bladder volume was 
overfilled (200% volume) compared to the planning scan. 
Isotropic expansions of 10mm and 12mm to the ITV provided 
adequate coverage on 37/40 and 39/40 CBCT’s respectively. 
The composite PTV offered reduced or comparable treated 
volumes to the manually modified PTV. 
Conclusions: A standard CTV-PTV margin does not ensure 
adequate target coverage. It is important to use bladder 
status to predict uterine motion but an additional margin is 
also required due to the impact of rectal filling and tumour 
regression. We recommend forming a composite CTV from 
'bladder empty' and 'bladder full' imaging with a 10 or 12mm 
PTV expansion to ensure an optimal balance between 
adequate coverage and minimisation of normal tissue 
toxicity.  
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Purpose/Objective: To compare treatment fields localised 
between radiographers and clinicians, to investigate if there 
is parity between them. Critically analyse geographical 
variations that exist and assess the subsequent feasibility and 
impact of a radiographer led service. 
Materials and Methods: 23 patients with metastatic spinal 
cord compression (MSCC) were prospectively sampled and 
once a field to treat the patient had been approved by a 
clinician, the CT data set was anonymised. 4 different 
radiographers not involved in the original planning performed 
a localisation for each patient. This gave a total of 92 
localisations to be compared to the clinicians approved 
fields. Agreement between a radiographer and clinician was 
defined as ≤0.5cm between field length, width and 3 
isocentre coordinates. If any one of the five parameters was 
greater than this tolerance, the localisation was not in 
agreement. The primary end point in this study was to 
investigate whether agreement between radiographer and 
clinician was achieved in minimum of 97% of the 
localisations. A secondary end point was to assess the patient 
pathway efficiency and the potential time that could be 
saved with a radiographer led approach. 
Results: 90/92 localisations showed parity therefore the rate 
of agreement between radiographers and clinicians in the 
localisation of radiotherapy fields for MSCC was 97.8% under 
the 0.5cm tolerance defined. In all of the measurable 
parameters, the average differences were less that 0.2cm 
such that there was a statistically significant difference in 
the data from the 0.5cm median (p<0.0001) that would 
establish no agreement between clinician and radiographer. 
Therefore robust parity between the two groups was 
established. An average delay in waiting for a clinician to 
approve the original field was 54 minutes (median and range 
were 48 and 141 minutes respectively).  
Conclusions; A very strong rate of agreement has been 
established along with minimal geographical or geometric 
differences in the localised fields. It has also been 
highlighted that considerable time could be saved in the 
patient’s pathway by removing the need to wait for clinician 
approval of the treatment field. By conducting this study, 
evidence has been collected that has enabled inferences to 
be drawn that a radiographer led service for the localisation 
of MSCC is a feasible option for improving the associated 
pathway and subsequent patient experience. 
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Purpose/Objective: This study examined the radiation doses 
delivered to salivary apparatus in patients receiving intensity 
modulated radiotherapy (IMRT) to the H&N over the past 7 
years. It examined the efficacy of parotid sparing, the effects 
of radiation dose to the submandibular glands (SMGs), minor 
and sublingual salivary glands on the incidence and severity 
of subjective xerostomia and investigated the quality of life 
of surviving patients. 
Materials and Methods: 7 years of retrospective dosimetric 
data were assessed based on the plans of surviving H&N 
cancer patients that were treated by IMRT. SMGs and a new 
surrogate contour representing the minor oral and sublingual 
tissue target (MOIST) were outlined. Doses received by the 
salivary apparatus were statistically analysed in conjunction 
with the EORTC QLQ-C30 and H&N35 module results which 
was completed by participants. 
Results: Mean global QoL was 66.6 out of 100. Emotional 
functioning had the lowest scores amongst the functional 
scales and physical functioning ranked the highest. The 
results of the questionnaire were compared according to sex, 
age and staging. There were no significant differences in any 
of the scores of males and females who completed the EORTC 
QLQ-C30. Regarding age, a statistically significant difference 
in physical functioning score across four different age groups 
(<50 years: n = 4, 50 – 59 years: n = 10, 60- 69 years: n = 20, 
>70 years: n = 7), p =.034 was identified. Significant 
differences in the physical functioning level, p=.024, fatigue 
symptoms, p=.006, and pain symptoms, p=.028 of patients 
with early stage disease and those with locally advanced 
disease were observed. 
Patient global QoL scores were not significantly different to 
scores of a normal population after IMRT. Global QoL scores 
were not influenced by gender, stage or treatment modalities 
in conjunction with IMRT. Dry mouth was the most prevalent 
symptom. Dry mouth scores were not influenced by gender, 
stage or the addition of different treatment modalities such 
as chemotherapy or surgery. There was a moderate and 
statistically significant relationship between xerostomia score 
and global QoL, R = -.428, N=39, p<0.01. Mean dose to the 
salivary apparatus was not correlated with subjective 
xerostomia. Mean dose to the salivary apparatus was not 
shown to have an impact on severity of subjective 
xerostomia. Mean dose to the individual salivary glands was 
not correlated with global QoL scores 
